AI-Enabled Pediatric Chronic Care Platform Supporting Families Between Visits
AI Pediatric Care Platform with 600 Families Served
On NextCompany since August 27, 2026 (today)
Location undisclosed
Business overview
An AI native pediatric digital health platform supports chronic care between visits. The company focuses on type 1 diabetes childhood obesity and growth hormone disorders. It serves approximately 600 families with 4 institutional relationships. A 4,000,000 dollar pipeline supports future growth. Management projects 1,300,000 dollars in 2026 operating income. Expansion potential includes oncology and autism. The platform seeks a strategic partner for acceleration.
Who is a good fit for this business
- Strategic acquirers in pediatric digital health seek this platform.
- Investors focused on AI health agents and chronic care management align.
- Partners wanting to expand into oncology and autism pathways fit.
Details
- Reason for selling
- Seeking a strategic partner, investor or acquirer to help accelerate scale.
- Real estate
- No real estate
Frequently Asked Questions
The platform focuses on type 1 diabetes childhood obesity and growth hormone disorders. Expansion potential includes oncology and autism. Mobile first support combines with empathic AI agents.
Approximately 600 families currently use the platform. Four active institutional relationships exist. A 4,000,000 dollar pipeline supports growth.
Management projects 1,300,000 dollars in 2026 operating income. The company seeks a strategic partner or investor. Reach is expected to exceed 1,000 families.
The platform seeks a strategic partner investor or acquirer. The goal is to accelerate scale. The model supports families between clinical visits.